Replies to post #266862 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

I took a picture with that canon sunstar...; ) I saw...
"It covers exposed PS thereby activating the patients' immune systems."

I have to interject the notion that merely covering or "capping" as CP stated is not enough. Say all the PS was covered in a bubble of Bavi with no other signal but a smooth surface? The immune system has nothing to recognize. Bavituximabs effector arm must create the correct signal to alert the immune system. That is the arm that is cut off for the imaging molecule.

Great posts I'm reading...

Enjoy the Day and remember...if Bavituximab is indeed working as expected...THEY have PPHM right where they wanted them....
imho

wook

[BCS Paladin]

Sounds like there will be several small open label I-O combo P1 trials producing patient data across a few different cancer indications. Certainly they'll be much faster than large P2 and P3 trials.

And still 5-7 years before we have any chance to actually sell something.

Thank goodness for AVID, our saving grace. LOL